Pharma & Healthcare

Nervous System Medications - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

The global market for Nervous System Medications was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Nervous System Medications was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nervous System Medications was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Nervous System Medications was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Nervous System Medications include Pfizer, Teva, Novartis, AstraZeneca, Takeda, Johnson & Johnson, EliLilly, Otsuka and Merck, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nervous System Medications, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nervous System Medications by region & country, by Type, and by Application.
The Nervous System Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nervous System Medications.
Market Segmentation
By Company
Pfizer
Teva
Novartis
AstraZeneca
Takeda
Johnson & Johnson
EliLilly
Otsuka
Merck
Yangtze River Pharmaceutical
Humanwell Healthcare
CSPC-NBP Pharmaceutical
Nhwa Pharmaceutical
Qilu Pharma
Segment by Type:
Anesthetic
Painkiller
Psychostimulants
Antiepileptic Drugs
Anti-Parkinson Drugs
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nervous System Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nervous System Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nervous System Medications in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Nervous System Medications Product Introduction
1.2 Global Nervous System Medications Market Size Forecast
1.2.1 Global Nervous System Medications Sales Value (2019-2030)
1.2.2 Global Nervous System Medications Sales Volume (2019-2030)
1.2.3 Global Nervous System Medications Sales Price (2019-2030)
1.3 Nervous System Medications Market Trends & Drivers
1.3.1 Nervous System Medications Industry Trends
1.3.2 Nervous System Medications Market Drivers & Opportunity
1.3.3 Nervous System Medications Market Challenges
1.3.4 Nervous System Medications Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nervous System Medications Players Revenue Ranking (2023)
2.2 Global Nervous System Medications Revenue by Company (2019-2024)
2.3 Global Nervous System Medications Players Sales Volume Ranking (2023)
2.4 Global Nervous System Medications Sales Volume by Company Players (2019-2024)
2.5 Global Nervous System Medications Average Price by Company (2019-2024)
2.6 Key Manufacturers Nervous System Medications Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nervous System Medications Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nervous System Medications
2.9 Nervous System Medications Market Competitive Analysis
2.9.1 Nervous System Medications Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nervous System Medications Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Medications as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Anesthetic
3.1.2 Painkiller
3.1.3 Psychostimulants
3.1.4 Antiepileptic Drugs
3.1.5 Anti-Parkinson Drugs
3.1.6 Others
3.2 Global Nervous System Medications Sales Value by Type
3.2.1 Global Nervous System Medications Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nervous System Medications Sales Value, by Type (2019-2030)
3.2.3 Global Nervous System Medications Sales Value, by Type (%) (2019-2030)
3.3 Global Nervous System Medications Sales Volume by Type
3.3.1 Global Nervous System Medications Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nervous System Medications Sales Volume, by Type (2019-2030)
3.3.3 Global Nervous System Medications Sales Volume, by Type (%) (2019-2030)
3.4 Global Nervous System Medications Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Nervous System Medications Sales Value by Application
4.2.1 Global Nervous System Medications Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nervous System Medications Sales Value, by Application (2019-2030)
4.2.3 Global Nervous System Medications Sales Value, by Application (%) (2019-2030)
4.3 Global Nervous System Medications Sales Volume by Application
4.3.1 Global Nervous System Medications Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nervous System Medications Sales Volume, by Application (2019-2030)
4.3.3 Global Nervous System Medications Sales Volume, by Application (%) (2019-2030)
4.4 Global Nervous System Medications Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nervous System Medications Sales Value by Region
5.1.1 Global Nervous System Medications Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nervous System Medications Sales Value by Region (2019-2024)
5.1.3 Global Nervous System Medications Sales Value by Region (2025-2030)
5.1.4 Global Nervous System Medications Sales Value by Region (%), (2019-2030)
5.2 Global Nervous System Medications Sales Volume by Region
5.2.1 Global Nervous System Medications Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nervous System Medications Sales Volume by Region (2019-2024)
5.2.3 Global Nervous System Medications Sales Volume by Region (2025-2030)
5.2.4 Global Nervous System Medications Sales Volume by Region (%), (2019-2030)
5.3 Global Nervous System Medications Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nervous System Medications Sales Value, 2019-2030
5.4.2 North America Nervous System Medications Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nervous System Medications Sales Value, 2019-2030
5.5.2 Europe Nervous System Medications Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nervous System Medications Sales Value, 2019-2030
5.6.2 Asia Pacific Nervous System Medications Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nervous System Medications Sales Value, 2019-2030
5.7.2 South America Nervous System Medications Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nervous System Medications Sales Value, 2019-2030
5.8.2 Middle East & Africa Nervous System Medications Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nervous System Medications Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nervous System Medications Sales Value
6.2.1 Key Countries/Regions Nervous System Medications Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nervous System Medications Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nervous System Medications Sales Value, 2019-2030
6.3.2 United States Nervous System Medications Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nervous System Medications Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nervous System Medications Sales Value, 2019-2030
6.4.2 Europe Nervous System Medications Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nervous System Medications Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nervous System Medications Sales Value, 2019-2030
6.5.2 China Nervous System Medications Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nervous System Medications Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nervous System Medications Sales Value, 2019-2030
6.6.2 Japan Nervous System Medications Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nervous System Medications Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nervous System Medications Sales Value, 2019-2030
6.7.2 South Korea Nervous System Medications Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nervous System Medications Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nervous System Medications Sales Value, 2019-2030
6.8.2 Southeast Asia Nervous System Medications Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nervous System Medications Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nervous System Medications Sales Value, 2019-2030
6.9.2 India Nervous System Medications Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nervous System Medications Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Nervous System Medications Product Offerings
7.1.5 Pfizer Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Introduction and Business Overview
7.2.3 Teva Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Teva Nervous System Medications Product Offerings
7.2.5 Teva Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Introduction and Business Overview
7.3.3 Novartis Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Novartis Nervous System Medications Product Offerings
7.3.5 Novartis Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Information
7.4.2 AstraZeneca Introduction and Business Overview
7.4.3 AstraZeneca Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AstraZeneca Nervous System Medications Product Offerings
7.4.5 AstraZeneca Recent Development
7.5 Takeda
7.5.1 Takeda Company Information
7.5.2 Takeda Introduction and Business Overview
7.5.3 Takeda Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Takeda Nervous System Medications Product Offerings
7.5.5 Takeda Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Information
7.6.2 Johnson & Johnson Introduction and Business Overview
7.6.3 Johnson & Johnson Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Johnson & Johnson Nervous System Medications Product Offerings
7.6.5 Johnson & Johnson Recent Development
7.7 EliLilly
7.7.1 EliLilly Company Information
7.7.2 EliLilly Introduction and Business Overview
7.7.3 EliLilly Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.7.4 EliLilly Nervous System Medications Product Offerings
7.7.5 EliLilly Recent Development
7.8 Otsuka
7.8.1 Otsuka Company Information
7.8.2 Otsuka Introduction and Business Overview
7.8.3 Otsuka Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Otsuka Nervous System Medications Product Offerings
7.8.5 Otsuka Recent Development
7.9 Merck
7.9.1 Merck Company Information
7.9.2 Merck Introduction and Business Overview
7.9.3 Merck Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Merck Nervous System Medications Product Offerings
7.9.5 Merck Recent Development
7.10 Yangtze River Pharmaceutical
7.10.1 Yangtze River Pharmaceutical Company Information
7.10.2 Yangtze River Pharmaceutical Introduction and Business Overview
7.10.3 Yangtze River Pharmaceutical Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Yangtze River Pharmaceutical Nervous System Medications Product Offerings
7.10.5 Yangtze River Pharmaceutical Recent Development
7.11 Humanwell Healthcare
7.11.1 Humanwell Healthcare Company Information
7.11.2 Humanwell Healthcare Introduction and Business Overview
7.11.3 Humanwell Healthcare Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Humanwell Healthcare Nervous System Medications Product Offerings
7.11.5 Humanwell Healthcare Recent Development
7.12 CSPC-NBP Pharmaceutical
7.12.1 CSPC-NBP Pharmaceutical Company Information
7.12.2 CSPC-NBP Pharmaceutical Introduction and Business Overview
7.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.12.4 CSPC-NBP Pharmaceutical Nervous System Medications Product Offerings
7.12.5 CSPC-NBP Pharmaceutical Recent Development
7.13 Nhwa Pharmaceutical
7.13.1 Nhwa Pharmaceutical Company Information
7.13.2 Nhwa Pharmaceutical Introduction and Business Overview
7.13.3 Nhwa Pharmaceutical Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Nhwa Pharmaceutical Nervous System Medications Product Offerings
7.13.5 Nhwa Pharmaceutical Recent Development
7.14 Qilu Pharma
7.14.1 Qilu Pharma Company Information
7.14.2 Qilu Pharma Introduction and Business Overview
7.14.3 Qilu Pharma Nervous System Medications Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Qilu Pharma Nervous System Medications Product Offerings
7.14.5 Qilu Pharma Recent Development
8 Industry Chain Analysis
8.1 Nervous System Medications Industrial Chain
8.2 Nervous System Medications Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nervous System Medications Sales Model
8.5.2 Sales Channel
8.5.3 Nervous System Medications Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Nervous System Medications Market Trends
Table 2. Nervous System Medications Market Drivers & Opportunity
Table 3. Nervous System Medications Market Challenges
Table 4. Nervous System Medications Market Restraints
Table 5. Global Nervous System Medications Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nervous System Medications Revenue Market Share by Company (2019-2024)
Table 7. Global Nervous System Medications Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Nervous System Medications Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Nervous System Medications Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Nervous System Medications Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Nervous System Medications Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Nervous System Medications
Table 13. Global Nervous System Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Medications as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Nervous System Medications Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Nervous System Medications Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Nervous System Medications Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Nervous System Medications Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Nervous System Medications Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Nervous System Medications Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Nervous System Medications Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Nervous System Medications Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Nervous System Medications Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Nervous System Medications Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Nervous System Medications Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Nervous System Medications Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Nervous System Medications Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Nervous System Medications Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Nervous System Medications Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Nervous System Medications Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Nervous System Medications Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Nervous System Medications Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Nervous System Medications Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Nervous System Medications Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Nervous System Medications Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Nervous System Medications Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Nervous System Medications Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Nervous System Medications Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Nervous System Medications Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Nervous System Medications Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Nervous System Medications Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Nervous System Medications Sales Value by Region (2019-2024) & (%)
Table 44. Global Nervous System Medications Sales Value by Region (2025-2030) & (%)
Table 45. Global Nervous System Medications Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Nervous System Medications Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Nervous System Medications Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Nervous System Medications Sales Volume by Region (2019-2024) & (%)
Table 49. Global Nervous System Medications Sales Volume by Region (2025-2030) & (%)
Table 50. Global Nervous System Medications Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Nervous System Medications Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Nervous System Medications Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Nervous System Medications Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Nervous System Medications Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Nervous System Medications Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Nervous System Medications Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer Company Information
Table 58. Pfizer Introduction and Business Overview
Table 59. Pfizer Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer Nervous System Medications Product Offerings
Table 61. Pfizer Recent Development
Table 62. Teva Company Information
Table 63. Teva Introduction and Business Overview
Table 64. Teva Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Teva Nervous System Medications Product Offerings
Table 66. Teva Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Introduction and Business Overview
Table 69. Novartis Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Novartis Nervous System Medications Product Offerings
Table 71. Novartis Recent Development
Table 72. AstraZeneca Company Information
Table 73. AstraZeneca Introduction and Business Overview
Table 74. AstraZeneca Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. AstraZeneca Nervous System Medications Product Offerings
Table 76. AstraZeneca Recent Development
Table 77. Takeda Company Information
Table 78. Takeda Introduction and Business Overview
Table 79. Takeda Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Takeda Nervous System Medications Product Offerings
Table 81. Takeda Recent Development
Table 82. Johnson & Johnson Company Information
Table 83. Johnson & Johnson Introduction and Business Overview
Table 84. Johnson & Johnson Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Johnson & Johnson Nervous System Medications Product Offerings
Table 86. Johnson & Johnson Recent Development
Table 87. EliLilly Company Information
Table 88. EliLilly Introduction and Business Overview
Table 89. EliLilly Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. EliLilly Nervous System Medications Product Offerings
Table 91. EliLilly Recent Development
Table 92. Otsuka Company Information
Table 93. Otsuka Introduction and Business Overview
Table 94. Otsuka Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Otsuka Nervous System Medications Product Offerings
Table 96. Otsuka Recent Development
Table 97. Merck Company Information
Table 98. Merck Introduction and Business Overview
Table 99. Merck Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Merck Nervous System Medications Product Offerings
Table 101. Merck Recent Development
Table 102. Yangtze River Pharmaceutical Company Information
Table 103. Yangtze River Pharmaceutical Introduction and Business Overview
Table 104. Yangtze River Pharmaceutical Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Yangtze River Pharmaceutical Nervous System Medications Product Offerings
Table 106. Yangtze River Pharmaceutical Recent Development
Table 107. Humanwell Healthcare Company Information
Table 108. Humanwell Healthcare Introduction and Business Overview
Table 109. Humanwell Healthcare Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Humanwell Healthcare Nervous System Medications Product Offerings
Table 111. Humanwell Healthcare Recent Development
Table 112. CSPC-NBP Pharmaceutical Company Information
Table 113. CSPC-NBP Pharmaceutical Introduction and Business Overview
Table 114. CSPC-NBP Pharmaceutical Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. CSPC-NBP Pharmaceutical Nervous System Medications Product Offerings
Table 116. CSPC-NBP Pharmaceutical Recent Development
Table 117. Nhwa Pharmaceutical Company Information
Table 118. Nhwa Pharmaceutical Introduction and Business Overview
Table 119. Nhwa Pharmaceutical Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Nhwa Pharmaceutical Nervous System Medications Product Offerings
Table 121. Nhwa Pharmaceutical Recent Development
Table 122. Qilu Pharma Company Information
Table 123. Qilu Pharma Introduction and Business Overview
Table 124. Qilu Pharma Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Qilu Pharma Nervous System Medications Product Offerings
Table 126. Qilu Pharma Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Nervous System Medications Downstream Customers
Table 130. Nervous System Medications Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Nervous System Medications Product Picture
Figure 2. Global Nervous System Medications Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nervous System Medications Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Nervous System Medications Sales Volume (2019-2030) & (K Units)
Figure 5. Global Nervous System Medications Sales Price (2019-2030) & (US$/Unit)
Figure 6. Nervous System Medications Report Years Considered
Figure 7. Global Nervous System Medications Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Nervous System Medications Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nervous System Medications Revenue in 2023
Figure 10. Nervous System Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Anesthetic Picture
Figure 12. Painkiller Picture
Figure 13. Psychostimulants Picture
Figure 14. Antiepileptic Drugs Picture
Figure 15. Anti-Parkinson Drugs Picture
Figure 16. Others Picture
Figure 17. Global Nervous System Medications Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Nervous System Medications Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Nervous System Medications Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Nervous System Medications Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Nervous System Medications Price by Type (2019-2030) & (US$/Unit)
Figure 22. Product Picture of Hospital Pharmacy
Figure 23. Product Picture of Retail Pharmacy
Figure 24. Product Picture of Online Pharmacy
Figure 25. Global Nervous System Medications Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Nervous System Medications Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Nervous System Medications Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Nervous System Medications Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Nervous System Medications Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Nervous System Medications Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Nervous System Medications Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Nervous System Medications Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Nervous System Medications Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Nervous System Medications Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Nervous System Medications Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Nervous System Medications Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Nervous System Medications Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Nervous System Medications Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Nervous System Medications Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Nervous System Medications Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Nervous System Medications Sales Volume (%), (2019-2030)
Figure 42. United States Nervous System Medications Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Nervous System Medications Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Nervous System Medications Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Nervous System Medications Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Nervous System Medications Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Nervous System Medications Sales Value by Application (%), 2023 VS 2030
Figure 48. China Nervous System Medications Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Nervous System Medications Sales Value by Type (%), 2023 VS 2030
Figure 50. China Nervous System Medications Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Nervous System Medications Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Nervous System Medications Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Nervous System Medications Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Nervous System Medications Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Nervous System Medications Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Nervous System Medications Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Nervous System Medications Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Nervous System Medications Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Nervous System Medications Sales Value by Application (%), 2023 VS 2030
Figure 60. India Nervous System Medications Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Nervous System Medications Sales Value by Type (%), 2023 VS 2030
Figure 62. India Nervous System Medications Sales Value by Application (%), 2023 VS 2030
Figure 63. Nervous System Medications Industrial Chain
Figure 64. Nervous System Medications Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies